Table 2 Case and NMT data per mode of reversal and time period

Surgical specialty

7932 (88%)

1105 (12%)

9037 (100%)

4549 (82%)

1006 (18%)

5555 (100%)

 General surgery

2049 (84%)

377 (16%)

2426 (27%)

1094 (76%)

355 (24%)

1449 (26%)

 Gynecologic surgery

760 (86%)

124 (14%)

884 (10%)

387 (78%)

106 (22%)

493 (9%)

 Urological surgery

765 (75%)

255 (25%)

1020 (11%)

416 (65%)

221 (35%)

637 (11%)

 Lung surgery

26 (81%)

6 (19%)

32 (0%)

20 (74%)

7 (26%)

27 (0%)

 Orthopaedic surgery

780 (90%)

83 (10%)

863 (10%)

412 (85%)

75 (15%)

487 (9%)

 Plastic surgery

445 (93%)

31 (7%)

476 (5%)

318 (90%)

35 (10%)

353 (6%)

 Neuro surgery

1093 (92%)

100 (8%)

1193 (13%)

688 (87%)

100 (13%)

788 (14%)

 Ear, nose and throat surgery

1141 (94%)

68 (6%)

1209 (13%)

621 (93%)

50 (7%)

671 (12%)

 Oral and maxillofacial surgery

740 (95%)

41 (5%)

781 (9%)

503 (93%)

37 (7%)

540 (10%)

 Eye surgery

77 (90%)

9 (10%)

86 (1%)

29 (78%)

8 (22%)

37 (1%)

 Radio therapy

16 (94%)

1 (6%)

17 (0%)

32 (97%)

1 (3%)

33 (1%)

 Other specialty

40 (80%)

10 (20%)

50 (1%)

29 (73%)

11 (28%)

40 (1%)

Open abdominal

1419 (18%)

341 (31%)

1.760 (19%)

731 (16%)

299 (30%)

1030 (19%)

Laparoscopic abdominal

747 (10%)

145 (13%)

892 (10%)

315 (7%)

142 (14%)

457 (8%)

Emergency surgery

1194 (15%)

283 (26%)

1477 (16%)

698 (15%)

294 (29%)

992 (18%)

Time in the OR in minutes mean; median (IQR)

192; 155 (110; 223)

151; 131 (83; 192)

187; 152 (106; 217)

197; 166 (115; 237)

155; 129 (89; 194)

189; 158 (108; 227)

NMT monitoring used

3380 (43%)

846 (77%)

4226 (47%)

2590 (57%)

948 (94%)

3538 (64%)

No (documented) NMT monitoring

4552 (57%)

259 (23%)

4811 (53%)

1959 (43%)

58 (6%)

2017 (36%)

PTC measured

125 (2%)

84 (8%)

209 (2%)

100 (2%)

68 (7%)

168 (3%)

Extubation in OR

7058 (89%)

1062 (96%)

8120 (90%)

4210 (93%)

998 (99%)

5208 (94%)

 TOFR 1.0 or more at extubation

997 (14%)

280 (26%)

1277 (16%)

1113 (26%)

386 (39%)

1499 (29%)

 TOFR 0.9–1.0 at extubation

481 (7%)

111 (10%)

592 (7%)

594 (14%)

178 (18%)

772 (15%)

 TOFR < 0.9 or only qualitative NMT monitor at extubation

1874 (27%)

455 (43%)

2329 (29%)

873 (21%)

384 (38%)

1257 (24%)

 No NMT data in anaesthesia record

3706 (53%)

216 (20%)

3922 (48%)

1630 (39%)

50 (5%)

1680 (32%)

 No NMT data in anaesthesia record, and no sugammadex

3706 (46%)

1630 (31%)

Rocuronium total dose in mg mean; median (IQR)

48; 40 (30; 60)

60; 50 (40; 80)

50; 40 (30; 60)

46; 40 (30; 50)

60; 50 (40; 80)

48; 40 (30; 60)

Rocuronium total dose in ED95 equivalents (0.31 mg/kg ABW) mean; median (IQR)

2.0; 1.7 (1.2; 2.4)

2.5; 2.0 (1.4; 3.4)

2.1; 1.7 (1.3; 2.6)

1.9; 1.7 (1.2; 2.3)

2.5; 2.2 (1.5; 3.2)

2.0; 1.7 (1.3; 2.6)

Sugammadex total dose in mg mean; median (IQR)

210; 200 (200; 200)

169; 200 (100; 200)

Sugammadex total dose in mg/kg ABW mean; median (IQR)

2.7; 2.4 (1.9; 3.0)

2.1; 2.0 (1.3; 2.7)

Magnesium chloride co-administration

365 (5%)

45 (4%)

410 (5%)

139 (3%)

35 (3%)

174 (3%)

Use of inhalational anaesthetic

3469 (44%)

485 (44%)

3954 (44%)

3644 (80%)

885 (88%)

4529 (82%)